At Janssen we take pride in our track record of delivering new products to market including those that originated outside our organization. In addition to our own Research and Development (R&D), we have a history of successfully integrating licensed and partnered products, to create an innovative portfolio focused on delivering meaningful healthcare outcomes for patients. In our five focus therapeutic areas (below), we have established a leadership position through our product portfolio, deep market insights and best in class commercial capabilities.
Building Strong, Long-Term Partnerships
The New Business Development team builds strong, long-term collaborations that deliver added value to our partnered programs. Our ambition is to be considered the partner of choice. We already have more than 150 collaborations, across all aspects of the healthcare spectrum, including those with large pharmaceutical companies, biotech companies, academic institutions, public-private partnerships and open campus initiatives.
Our Areas of Interest
Our efforts are focused on five key therapeutic areas:
- Cardiovascular & Metabolism
- Immunology
- Infectious Diseases & Vaccines
- Neuroscience
- Oncology
Within these areas the EMEA New Business Development team is interested in partnerships around late stage development, registration or already marketed products. We are keen to discuss well-differentiated opportunities that will deliver value to our patients and will fit with our aspiration of being a transformational medical innovator.
Collaborations have formed an essential part of our heritage and we are committed to working with our partners to achieve this goal.”
Extend Your Reach
Our operational strength across the entire EMEA region – including Russia, Turkey and other Emerging Markets – will help you extend your reach to many more patients across the globe.
Our team is distributed throughout the EMEA region and this in-depth knowledge of the markets enables us to accurately assess the value of an opportunity in rapidly evolving local market conditions.
Contact Our Team
If you would like to talk to us about your product or a partnership idea, please contact us today. We’ll ensure that you are connected with the appropriate person and that you receive a prompt reply: [email protected].
Günter Huhle, MD, PhD, MSc
Vice President, New Business Development & Mature Brands
Chris Vaes, MSc, MBA
Director, New Business Development, Emerging Markets, Therapeutic Areas
Alexandr Krajhanzl, PhD
Director, New Business Development, Mid-Size Markets; Franchise Lead, Infectious Diseases
Marc de Hullu, MSc
Executive Director, Alliance Management
Letizia Goretti
Director, Partnership Development
Pierre Quelet, PhD, MBA
Country Lead, France; Franchise Lead, Metabolics
Laurence Mallick, MBA
Country Lead, Spain; Franchise Lead, Neuroscience
Filipa Costa, MSc, MBA
Country Lead, Italy; Franchise Lead, Oncology
Renier Van Dinter, MSc, MM
Country Lead, Benelux; Franchise Lead, Cardiovascular
Ahmed Mohamed, PhD, BSc
Country Lead, UK; Franchise Lead, Immunology
Marcus Stüttgen, MBA
Country Lead, Germany; Franchise Lead, Vaccines